Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2017

01-08-2017 | Editorial

The dream of imaging coronary artery inflammation with FDG PET/CT imaging

Authors: R. Glenn Wells, PhD, FCCPM, Terrence D. Ruddy, MD, FRCPC

Published in: Journal of Nuclear Cardiology | Issue 4/2017

Login to get access

Excerpt

Inflammation plays a major role in the development of atherosclerotic plaque1 and has been proposed as a marker of plaque vulnerability to identify patients at risk of vascular events.2 Plaque inflammation is characterized by increased macrophage infiltration and FDG uptake has been shown to correlate strongly with the number of macrophages present in plaques.3 Rudd et al showed that FDG accumulated and could be measured in vivo in carotid artery plaques associated with recent transient ischemic attacks but that asymptomatic arteries had less FDG accumulation.4 Thus, FDG uptake can be used to measure the degree of inflammation in tissues as confirmed with carotid endarterectomy specimens using CD-68 immunohistochemistry.5 FDG uptake in carotid arteries has also been shown to correlate with anatomical and histological features of plaques that are at high risk for rupturing.6 Carotid inflammation measured with FDG PET/CT has been shown to predict subsequent ipsilateral cerebrovascular events in a prospective study of 60 patients with recent stroke.7
Literature
1.
go back to reference Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:2045-51.CrossRef Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:2045-51.CrossRef
2.
go back to reference Tarkin JM, Joshi FR, Rudd JH. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol 2014;11:443-57.CrossRef Tarkin JM, Joshi FR, Rudd JH. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol 2014;11:443-57.CrossRef
3.
go back to reference Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245-50.PubMed Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245-50.PubMed
4.
go back to reference Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18f]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11.CrossRef Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18f]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11.CrossRef
5.
go back to reference Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818-24.CrossRef Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818-24.CrossRef
6.
go back to reference Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging 2012;5:69-77.CrossRef Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging 2012;5:69-77.CrossRef
7.
go back to reference Marnane M, Merwick A, Sheehan OC, Hannon N, Foran P, Grant T, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012;71:709-18.CrossRef Marnane M, Merwick A, Sheehan OC, Hannon N, Foran P, Grant T, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012;71:709-18.CrossRef
8.
go back to reference Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA, et al. Feasibility of FDG Imaging of the Coronary Arteries Comparison Between Acute Coronary Syndrome and Stable Angina. J Am Coll Cardiol Cardiovasc Imaging 2010;3:388-97.CrossRef Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA, et al. Feasibility of FDG Imaging of the Coronary Arteries Comparison Between Acute Coronary Syndrome and Stable Angina. J Am Coll Cardiol Cardiovasc Imaging 2010;3:388-97.CrossRef
9.
go back to reference Nitta Y, Tahara N, Tahara A, Honda A, Kodama N, Mizoguchi M, et al. Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus Evaluation by FDG-PET/CT Imaging. J Am Coll Cardiol Cardiovasc Imaging 2013;6:1172-82.CrossRef Nitta Y, Tahara N, Tahara A, Honda A, Kodama N, Mizoguchi M, et al. Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus Evaluation by FDG-PET/CT Imaging. J Am Coll Cardiol Cardiovasc Imaging 2013;6:1172-82.CrossRef
10.
go back to reference Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate. High-Fat Preparation. J Nucl Med 2009;50:563-8.PubMed Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate. High-Fat Preparation. J Nucl Med 2009;50:563-8.PubMed
11.
go back to reference Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 2014;383:705-13.CrossRef Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 2014;383:705-13.CrossRef
12.
go back to reference Sadeghi MM. 18F-FDG PET and vascular inflammation: Time to refine the paradigm? J Nucl Cardiol 2015;22:319-24.CrossRef Sadeghi MM. 18F-FDG PET and vascular inflammation: Time to refine the paradigm? J Nucl Cardiol 2015;22:319-24.CrossRef
13.
go back to reference Emami H, Tawakol A. Noninvasive imaging of arterial inflammation using FDG-PET/CT. Curr Opin Lipidol 2014;25:431-7.CrossRef Emami H, Tawakol A. Noninvasive imaging of arterial inflammation using FDG-PET/CT. Curr Opin Lipidol 2014;25:431-7.CrossRef
14.
go back to reference Aggarwal NR, Snipelisky D, Young PM, Gersh BJ, Cooper LT, Chareonthaitawee P. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 2015;16:949-58.CrossRef Aggarwal NR, Snipelisky D, Young PM, Gersh BJ, Cooper LT, Chareonthaitawee P. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 2015;16:949-58.CrossRef
15.
16.
go back to reference Suda M, Kiriyama T, Ishihara K, Onoguchi M, Kobayashi Y, Sakurai M, et al. The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study. J Nucl Cardiol 2016. doi:10.1007/s12350-016-0510-7.CrossRef Suda M, Kiriyama T, Ishihara K, Onoguchi M, Kobayashi Y, Sakurai M, et al. The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study. J Nucl Cardiol 2016. doi:10.​1007/​s12350-016-0510-7.CrossRef
17.
go back to reference Lamare F, Le Maitre A, Dawood M, Schäfers KP, Fernandez P, Rimoldi OE, et al. Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging. Med Phys 2014;41:072504.CrossRef Lamare F, Le Maitre A, Dawood M, Schäfers KP, Fernandez P, Rimoldi OE, et al. Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging. Med Phys 2014;41:072504.CrossRef
18.
go back to reference Slomka PJ, Rubeaux M, Le Meunier L, Dey D, Lazewatsky JL, Pan T, Dweck MR, et al. Dual-Gated Motion-Frozen Cardiac PET with Flurpiridaz F 18. J Nucl Med 2015;56:1876-81.CrossRef Slomka PJ, Rubeaux M, Le Meunier L, Dey D, Lazewatsky JL, Pan T, Dweck MR, et al. Dual-Gated Motion-Frozen Cardiac PET with Flurpiridaz F 18. J Nucl Med 2015;56:1876-81.CrossRef
19.
go back to reference Presotto L, Busnardo E, Perani D, Gianolli L, Gilardi MC, Bettinardi V. Simultaneous reconstruction of attenuation and activity in cardiac PET can remove CT misalignment artifacts. J Nucl Cardiol 2015. doi:10.1007/s12350-015-0239-8.CrossRef Presotto L, Busnardo E, Perani D, Gianolli L, Gilardi MC, Bettinardi V. Simultaneous reconstruction of attenuation and activity in cardiac PET can remove CT misalignment artifacts. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0239-8.CrossRef
20.
go back to reference Beer AJ, Pelisek J, Heider P, Saraste A, Reeps C, Metz S, et al. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. J Am Coll Cardiol Cardiovasc Imaging 2014;7:178-87.CrossRef Beer AJ, Pelisek J, Heider P, Saraste A, Reeps C, Metz S, et al. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. J Am Coll Cardiol Cardiovasc Imaging 2014;7:178-87.CrossRef
Metadata
Title
The dream of imaging coronary artery inflammation with FDG PET/CT imaging
Authors
R. Glenn Wells, PhD, FCCPM
Terrence D. Ruddy, MD, FRCPC
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0549-5

Other articles of this Issue 4/2017

Journal of Nuclear Cardiology 4/2017 Go to the issue